Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Applications are invited for the prestigious role of Director of the MRC Weatherall Institute of Molecular Medicine (MRC WIMM).

The appointee will provide inspiring scientific and strategic leadership for this world leading research institute within the Radcliffe Department of Medicine (RDM). S/he will be responsible for the overall management of the Institute including pursuing a strong vision for translational research into human health, developing scientific infrastructure, maintaining local, national and international relationships which contribute to the profile of the Institute and helping to nurture working relationships with sponsors, including the Institute’s major sponsor the Medical Research Council (MRC). A key responsibility will be to develop synergies across the MRC’s Molecular Haematology and Human Immunology Units and other science within the MRC WIMM. 

The MRC WIMM’s mission is to undertake internationally leading research into the processes underlying normal cell and molecular biology, to determine the mechanisms by which these processes are perturbed in inherited and acquired human diseases and to translate this research to improve human health.

The successful candidate will be an internationally leading and innovative scientist of the highest calibre with exceptional leadership and management skills, whose ultimate research goal is to improve human health. S/he will ensure that the environment of academic excellence within the MRC WIMM and RDM is maintained.

The appointee will hold a PhD/DPhil, MD or equivalent with significant post-qualification research experience.

Applications for this vacancy are to be made online. To apply for this role and for further details, including a job description and selection criteria, please click on the link below:-

https://www.recruit.ox.ac.uk/pls/hrisliverecruit/erq_jobspec_version_4.jobspec?p_id=137797

The closing date for this position is 12.00 midday on Monday 3rd December 2018.

Applicants for this position may also be interested in applying for the role of Director of the MRC Molecular Haematology Unit which is also being advertised here and can be held in conjunction with the position of Institute Director.

Applications are particularly welcome from women and black and minority ethnic candidates, who are under-represented in academic posts in Oxford

Similar stories

New study maps the development of the human intestine

MRC HIU RDM

Researchers in the Simmons lab chart the embryonic origins and appearance of diverse intestinal cellular compartments, with important implications for intestinal diseases.

MRC HIU appoints new Director

MRC HIU RDM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Research unpicks why immune responses decrease with age

MRC MHU

Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.

Study uncovers how low blood iron diminishes immune response

MRC HIU NDM RDM

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells